Literature DB >> 22286543

Intensive radiographic and biomarker surveillance in stage II and III colorectal cancer.

Ahmad Fora1, Annie Patta, Kristopher Attwood, Gregory Wilding, Marwan Fakih.   

Abstract

OBJECTIVE: The objective of this study was to determine the rate of salvage resections in patients with stage II and III colorectal cancer following intensive surveillance in a comprehensive cancer center.
METHODS: Patients with stage II and III colorectal cancer with a minimum follow-up of 3 years were included. Carcinoembryonic antigen was obtained every 3 months for 2 years and then every 6 months for years 3-5. CT scans of the chest, abdomen and pelvis were performed every 6 months for 2 years and then yearly for years 3-5. Colonoscopy was performed at year 1 and then every 3 years.
RESULTS: One hundred and seventy-seven patients were followed for a median of 60 months; 44 patients were diagnosed with recurrent disease. CT was the first sign of recurrence in 68% of patients. Carcinoembryonic antigen test was normal in 20 patients (45%) at the time of disease recurrence. Twenty-five patients (57%) with recurrent disease underwent curative-intent resection, 12 of whom are still cancer free at a median follow-up of 81 months.
CONCLUSIONS: In this retrospective study, intensive radiographic screening was associated with a high salvage resection rate, which led to favorable clinical outcomes. Randomized clinical trials are urgently needed to define the optimal duration and schedule of radiographic screening in stage II and III colorectal cancer.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22286543     DOI: 10.1159/000333855

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  8 in total

1.  Elevated Serum Carcinoembryonic Antigen Is Associated with a Worse Survival Outcome of Patients After Liver Resection for Hepatocellular Carcinoma: a Propensity Score Matching Analysis.

Authors:  Jianwei Liu; Yong Xia; Lehua Shi; Xifeng Li; Lu Wu; Zhenlin Yan
Journal:  J Gastrointest Surg       Date:  2016-10-11       Impact factor: 3.452

2.  How often should we perform surveillance colonoscopy after surgery for colorectal cancer?

Authors:  Taku Sakamoto; Takahisa Matsuda; Takeshi Nakajima; Yutaka Saito
Journal:  Int J Colorectal Dis       Date:  2012-11-21       Impact factor: 2.571

3.  Prognostic value of the combination of pre- and postoperative C-reactive protein in colorectal cancer patients.

Authors:  Manabu Yamamoto; Hiroaki Saito; Chihiro Uejima; Akimitsu Tanio; Seigo Takaya; Teruhisa Sakamoto; Soichiro Honjo; Yoshihiko Maeta; Keigo Ashida; Yoshiyuki Fujiwara
Journal:  Surg Today       Date:  2018-06-26       Impact factor: 2.549

Review 4.  Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen: Comparison of Surveillance Strategies Among Patients Who Underwent Resection of Colorectal Cancer-A Systematic Review and Meta-analysis.

Authors:  Zaiba Shafik Dawood; Laura Alaimo; Henrique A Lima; Zorays Moazzam; Chanza Shaikh; Ahmed Sayed Ahmed; Muhammad Musaab Munir; Yutaka Endo; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2022-10-11       Impact factor: 4.339

Review 5.  Alternatives for the intensive follow-up after curative resection of colorectal cancer. Potential novel biomarkers for the recommendations.

Authors:  Enikő Orosz; István Ember; Katalin Gombos; László Tóth; Ádám Tarpay; Ákos Pap; Szabolcs Ottó
Journal:  Pathol Oncol Res       Date:  2013-07-19       Impact factor: 3.201

6.  Combination of C-reactive Protein and Monocyte Count Is a Useful Prognostic Indicator for Patients With Colorectal Cancer.

Authors:  Manabu Yamamoto; Hiroaki Saito; Kazushi Hara; Ken Sugezawa; Chihiro Uejima; Akimitsu Tanio; Yoichiro Tada; Kyoichi Kihara; Teruhisa Sakamoto; Soichiro Honjo; Yoshiyuki Fujiwara
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

7.  Prognostic Value of Combined Tumor Marker and Controlling Nutritional Status (CONUT) Score in Colorectal Cancer Patients.

Authors:  Manabu Yamamoto; Hiroaki Saito; Chihiro Uejima; Akimitsu Tanio; Yoichiro Tada; Tomoyuki Matsunaga; Teruhisa Sakamoto; Soichiro Honjo; Keigo Ashida; Yoshiyuki Fujiwara
Journal:  Yonago Acta Med       Date:  2019-03-28       Impact factor: 1.641

8.  Evaluation of Comparative Surveillance Strategies of Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen Levels in Patients With Resected Colorectal Cancer.

Authors:  Marwan Fakih; Jaideep Sandhu; Chongkai Wang; Jae Kim; Yi-Jen Chen; Lily Lai; Kurt Melstrom; Andreas Kaiser
Journal:  JAMA Netw Open       Date:  2022-03-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.